| Product Code: ETC9402229 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Drug Discovery Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Drug Discovery Market - Industry Life Cycle |
3.4 South Korea Drug Discovery Market - Porter's Five Forces |
3.5 South Korea Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 South Korea Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 South Korea Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development by pharmaceutical companies |
4.2.2 Technological advancements in drug discovery processes |
4.2.3 Rising prevalence of chronic diseases in South Korea |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with drug discovery and development |
4.3.3 Limited availability of skilled professionals in the field of drug discovery |
5 South Korea Drug Discovery Market Trends |
6 South Korea Drug Discovery Market, By Types |
6.1 South Korea Drug Discovery Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Drug Discovery Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 South Korea Drug Discovery Market Revenues & Volume, By Small Molecule Drugs, 2021- 2031F |
6.1.4 South Korea Drug Discovery Market Revenues & Volume, By Biologic Drugs, 2021- 2031F |
6.2 South Korea Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Korea Drug Discovery Market Revenues & Volume, By High Throughput Screening, 2021- 2031F |
6.2.3 South Korea Drug Discovery Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.2.4 South Korea Drug Discovery Market Revenues & Volume, By Combinatorial Chemistry, 2021- 2031F |
6.2.5 South Korea Drug Discovery Market Revenues & Volume, By Nanotechnology, 2021- 2031F |
6.2.6 South Korea Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F |
6.3 South Korea Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea Drug Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 South Korea Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.3.4 South Korea Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F |
7 South Korea Drug Discovery Market Import-Export Trade Statistics |
7.1 South Korea Drug Discovery Market Export to Major Countries |
7.2 South Korea Drug Discovery Market Imports from Major Countries |
8 South Korea Drug Discovery Market Key Performance Indicators |
8.1 Research and development expenditure in the pharmaceutical sector |
8.2 Number of patents filed for new drug discoveries |
8.3 Collaboration agreements between pharmaceutical companies and research institutions in South Korea |
9 South Korea Drug Discovery Market - Opportunity Assessment |
9.1 South Korea Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 South Korea Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 South Korea Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Drug Discovery Market - Competitive Landscape |
10.1 South Korea Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 South Korea Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here